The company said, "For the full year 2023, the Company expects net revenues to increase at least 10% year-over-year, and gross margins to be between 58% and 62%."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on OPRX:
- OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients
- OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results
- OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET
- OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
- OptimizeRx resumed with a Buy at B. Riley